BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →
vpside

AURA

Aura Biosciences, Inc.
Nasdaq · Biological products, (no diagnostic substances) (SIC 2836) · FY ends 31 Dec

Revenue, quarterly

—
Not reported in this company’s filings
Company filingsvpside.com

Gross margin, trailing twelve months

—
Not reported in this company’s filings
Company filingsvpside.com

Cash and cash equivalents, quarter-end

$68M−36.8% year on year
$150M$100M$50M$0
Q4 ’21Q1 ’23Q1 ’24Q2 ’25Q2 ’26
Company filings · 10-Q filed 11 Aug 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

−$103M
$50M$0−$50M−$100M−$150M
Q4 ’22Q4 ’23Q3 ’24Q3 ’25Q2 ’26
Company filings · 10-Q filed 11 Aug 2026 · TTM = last four quartersvpside.com
Chart 05 is empty
Chart 06 is empty